Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

233.99
Delayed Data
As of Mar 22
 -0.56 / -0.24%
Today’s Change
184.50
Today|||52-Week Range
282.59
+11.42%
Year-to-Date
Corporate Share Repurchases Decline for 2nd Year in a Row
Mar 22 / GuruFocus News - Paid Partner Content
Buying Allergan
Mar 21 / TheStreet.com - Paid Partner Content
Saba Capital Management, L.P. Buys Allergan PLC, Alpine Total Dynamic Dividend Fund, ...
Mar 21 / GuruFocus News - Paid Partner Content
Adding to Allergan
Mar 21 / TheStreet.com - Paid Partner Content
David Tepper Takes Big Risks for Big Rewards
Mar 21 / GuruFocus News - Paid Partner Content
North Tide Capital, Llc Buys Impax Laboratories, Allergan PLC, Accuray, Sells Communi...
Mar 20 / GuruFocus News - Paid Partner Content
Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod
Mar 21 / Zacks.com - Paid Partner Content
Saba Capital Management, L.P. Buys Allergan PLC, Alpine Total Dynamic Dividend Fund, ...
Mar 17 / GuruFocus News - Paid Partner Content
Bidding for 4 'Keepers'
Mar 21 / TheStreet.com - Paid Partner Content
Pharma Stock Roundup: AstraZeneca's Lynparza Impresses in Study, Merck Drug Label Exp...
Mar 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close234.55
Today’s open234.21
Day’s range233.35 - 236.41
Volume2,228,947
Average volume (3 months)4,359,569
Market cap$78.4B
Dividend yield1.20%
Data as of 03/22/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+18.74%
Earnings growth (next 5 years)+11.50%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book1.10

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.61+2.01%
ABTAbbott Laboratories+0.01+0.02%
NVONovo Nordisk+0.22+0.65%
LLYEli Lilly and Co+0.63+0.75%
Data as of 03/22/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)$3.39
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs